Subscribe To

Price Alert Latest News Economic Calendar News

PSYCF / Psyched Wellness reports additional positive results from preclinical oral toxicity study of Amanita Muscaria (AME-1)

Psyched Wellness Ltd reported additional positive findings from the preclinical 14-day oral toxicity study with Amanita Muscaria (AME-1), which was performed in conjunction with an analysis of its impact on gut epithelial cells. The company said the invivo study via oral supplementation with AME-1 focused on the potential bioactive effects on the immune receptors Toll-like Receptor-2 (TLR-2) and Dectin-1, both found in gut epithelial cells, which play an important role in defensive immune system mechanisms against pathogens. Read More

Demo Live Account See Partner Details

Content Topics

Umatrin

Holding

Limited

Umhl

Psyched

Wellness

Reports

Additional

Positive

Results

Preclinical

Toxicity

Amanita

Muscaria

ame 1

Stock

PSYCF

Posted: Feb 3 2022, 09:08

Author Name: Proactive Investors

PSYCF News

By Newsfile Corp
May 23, 2023

Psyched Wellness Is Excited To Announce The Launch of Amanita Gummies with My Crew Doses Inc., a Natural Formulation House and Brand

Toronto, Ontario--(Newsfile Corp. - May 23, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life s

By Newsfile Corp
March 21, 2023

Psyched Wellness Is Pleased to Announce That Calm Has Shipped to National Sales and Distribution Partner TruLife Distribution

Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life

By Newsfile Corp
March 9, 2023

Psyched Wellness Is Pleased to Announce That Calm Will Be Marketed at the ECRM Conference and the Natural Products Expo West Through Its New Distribution Partnerships

Toronto, Ontario--(Newsfile Corp. - March 9, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life

By Proactive Investors
February 22, 2023

Psyched Wellness launches affiliate program for its Amanita Muscaria-derived extract Calm

Psyched Wellness Ltd (CSE:PSYC, OTCQB:PSYCF) announced the launch of its new affiliate program which will allow members of its community to benefit fr

By Proactive Investors
February 15, 2023

Psyched Wellness announces sales partnership with Spacestation CPG for its proprietary Amanita Muscaria mushroom product Calm

Psyched Wellness Ltd (CSE:PSYC, OTCQB:PSYCF) has announced a new partnership with Spacestation CPG who will act as a sales broker for Psyched's propri

By Proactive Investors
January 24, 2023

Psyched Wellness announces launch of e-commerce fulfillment with ShipHero8

Psyched Wellness Ltd (CSE:PSYC, OTCQB:PSYCF) has announced that it has officially launched with fulfillment partner ShipHero, enabling customers to r

By Proactive Investors
November 8, 2022

Psyched Wellness announces purchase agreement with Choice Companies for its Amanita Muscaria mushroom tincture Calm

Psyched Wellness Ltd (CSE:PSYC, OTCQB:PSYCF) said it has entered into a purchase agreement with New York-based Choice Companies Wholesale and Distribu

By Proactive Investors
September 6, 2022

Psyched Wellness inks key supply agreements ahead of anticipated launch of its first Amanita Muscaria mushroom-derived product Calm

Psyched Wellness Ltd (CSE:PSYC, OTCQB:PSYCF) said it has signed two long-term supply agreements for Amanita Muscaria mushrooms which should provide t

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.